Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy Study of LX103 Treatment of X-Linked Retinoschisis (XLRS)
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Summary
The goal of this study is to evaluate the safety and efficacy of LX103 treatment of X-linked retinoschisis. This study will enroll subjects aged ≥ 6 years old to receive a single unilateral intravitreal (IVT) injection of LX103 to evaluate its safety and efficacy.
Official title: An Open Label Dose Escalation Clinical Trial to Evaluate the Safety and the Efficacy of LX103 in Patients With X-Linked Retinoschisis (XLRS)
Key Details
Gender
MALE
Age Range
6 Years - Any
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2022-12-13
Completion Date
2028-08
Last Updated
2023-04-18
Healthy Volunteers
No
Conditions
Interventions
LX103 Injection
Qualified subjects will receive a single unilateral intravitreal injection of LX103 at Day 0 in the trial.
Locations (1)
Shanghai General Hospital, Shanghai Jiao Tong University
Shanghai, China